These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7927616)

  • 1. Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.
    Krishnamurti L; Charan VD; Desai N; Pati H; Choudhry VP
    Indian J Pediatr; 1994; 61(2):179-82. PubMed ID: 7927616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
    Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
    Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
    Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins.
    Borgna-Pignatti C; Battisti L; Zecca M; Locatelli F
    Br J Haematol; 1994 Nov; 88(3):618-20. PubMed ID: 7819076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
    Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
    J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
    Yetgin S; Aytaç S; Olcay L; Tunç B; Ozbek N; Aydinok Y
    Turk J Pediatr; 2010; 52(2):126-31. PubMed ID: 20560246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura.
    Gringeri A; Cattaneo M; Santagostino E; Mannucci PM
    Br J Haematol; 1992 Mar; 80(3):337-40. PubMed ID: 1581213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
    Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
    Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
    J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How we use WinRho in patients with idiopathic thrombocytopenic purpura.
    Stotler BA; Schwartz J
    Transfusion; 2015 Nov; 55(11):2547-50. PubMed ID: 26094894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequelae of treatment of ITP with anti-D (Rho) immunoglobulin.
    Imbach P; Kühne T
    Lancet; 2000 Aug; 356(9228):447-8. PubMed ID: 10981885
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura.
    Scaradavou A; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):52-7. PubMed ID: 9523749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.